InvestorsHub Logo
icon url

dia76ca

10/18/12 6:19 PM

#100024 RE: EYEBUYSTOX #100019

YES YOU ARE EXAGGERATING! You even go so far as to say "Even if the lead investigator comes out and says it's a cure, the public will laugh." Nonsense. The public would rejoice and so would I. And PPHM could sign a partnership on pancreatic data alone if it is outstanding.
icon url

spacey

10/18/12 6:38 PM

#100032 RE: EYEBUYSTOX #100019

I think you are wrong about how the public will receive future data. (Hopefully) the screw up was NOT THEIR FAULT at PPHM.

Since Avid manufactures bevacizumab, I sure the heck hope they didnt send out the wrong DRUG. I've never like the fact the 2 drugs are so close in spelling, bavituxumab, bavacizumab.


I listened to the previous conference call to hear the excitement over the results of phase 2. If it is proven NOT THEIR FAULT and the results remains good is what I want to hear and the investment community and the partnering companies.

If pancreatic trial is a good one, great for patients with so little choice of treatment and a death sentence of a diagnosis, great for company and great for investors and interested partners.

Each indication validated increase share value in the future. Breast, Lung, Pancreatic worth how many BILLIONS in the future. We know from prior trial something, it works!
icon url

Frustrated

10/18/12 9:26 PM

#100056 RE: EYEBUYSTOX #100019

Or at least not until Major discrepancies are found again, IMO. And that's the whole problem. If the company cannot recover the data from a gold standard FDA approved double blinded, placebo controlled multi-center trial HOW IN THE WORLD CAN ANYONE TRUST ANYTHING THE COMPANY EVER SAYS AS IT RELATES TO ANY FUTURE TRIAL EVER?!?!?! I'm not exaggerating. I'm curious how.

If the 2nd line NSCLC issue never gets resolved, this company is going nowhere. No data will be received well by the investment community, IMO. Even amazing pancreatic survival data will be mocked by everyone. Even if the lead investigator comes out and says it's a cure, the public will laugh. Until a partner steps up with a monetary commitment there are no trial results aside from FDA Audited 2nd line NSCLC results that will help the PPS. Anything the company says going forward is just fluff until then. It's sad...it really is. So many careers and so much hard work all screwed by some data mix up. So sad. All, IMO.


Best and most factual post of the night! Why would anybody trust any data coming from these guys. I see the FBI is no longer investigating the conspiracy that this was bothched on purpose! LOL!

BTW is it me or does it seem now that it may not even be a 3rd party error to boot!